EU nod for Gedeon’s novel antipsychotic Reagila
admin 19th July 2017 Uncategorised 0European regulators have approved Gedeon Richter’s novel antipsychotic Reagila as a new option for the treatment of patients with schizophrenia.
More: EU nod for Gedeon’s novel antipsychotic Reagila
Source: News